Skip to main content
. 2020 Nov 2;12:11085–11093. doi: 10.2147/CMAR.S277724

Table 3.

The Relationship of Pathogenic mtDNA Somatic Mutations with Platinum Resistance and Relapse of HGSOC

No. of Patients
(%)
No. of Platinum- Resistant/Relapsed Patients (%) p-value
Carry pathogenic heteroplasmic mtDNA somatic mutations 10 (100) 8 (80.0) 0.035*
DO NOT carry any pathogenic mtDNA somatic mutations 6 (100) 1 (16.7)

Note: *By Fisher exact test. Bold, p-values less than 0.05.

Abbreviations: HGSOC, high-grade serous adenocarcinoma; mt, mitochondrial.